Head And Neck Cancer | sciencenewsnet.in

Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid tumors

The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

Announcement

New Information from NCCN on Overcoming Challenges for People with Head and Neck Cancers

May 26, 2020 sarah Jonas Head & Neck Cancer, Head And Neck Cancer, Head And Neck Cancers, Health Literacy, HPV vaccination, Hpv Vaccine, HPV-related cancer, HPV-related cancers, HPV-related throat cancer, Human Papilloma Virus, Nasopharyngeal, National Comprehensive Cancer Network, NCCN, NCCN Foundation, NCCN Guidelines for Patients, oropharyngeal cancer, oropharyngeal squamous cell carcinoma, Patient Information

Newly-completed series of patient guidelines from National Comprehensive Cancer Network (NCCN) shares expert advice with patients and caregivers on treatment and prevention for most common head and neck cancers, including some that are HPV-related.

Research Results

Absent p53, oral cancers recruit and reprogram nerves to fuel tumor growth

February 12, 2020 sarah Jonas Cancer, Head And Neck Cancer, Md Anderson, MD Anderson Cancer Center, MD Anderson Cancer Center Houston, Tumor

Loss of an important tumor-suppressing gene allows head and neck cancer to spin off signals to nearby nerves, changing their function and recruiting them to the tumor, where they fuel growth and cancer progress.

Research Results

Gaps in Cure Rate Appear Linked to Race and Insurance Status for a Common HPV-Related Cancer, According to New Research

February 6, 2020 sarah Jonas Head & Neck Cancer, Head And Neck Cancer, HPV, HPV-related cancers, jnccn, JNCCN - Journal of the National Comprehensive Cancer Network, National Comprehensive Cancer Network, NCCN, Racial Disparities

Largest population-based analysis on factors that affect survival outcomes for HPV-positive oropharyngeal squamous cell carcinoma of the head and neck (SCCHN) find significant racial and socioeconomic disparities, according to new study in JNCCN-Journal of the National Comprehensive Cancer Network.

Research Results

Botanical drug is shown to help patients with head and neck cancers

February 5, 2020 sarah Jonas Cancer Research, Head And Neck Cancer, Turmeric, UCLA

In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers. These cancers are located in the head and the neck.
APG-157 is made up of multiple compounds produced by plants, including curcumin. UCLA Jonsson Comprehensive Cancer Center researchers found that treatment with this botanical drug resulted in high concentrations of curcumin and its byproducts circulating in the blood and absorbed by tumor tissues within three hours after being taken orally.